UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.314

Sortiert nach

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States

Human vaccines & immunotherapeutics, 2018-01, Vol.14 (8), p.2016-2024

2018

Volltextzugriff (PDF)

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Volltextzugriff (PDF)

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Human vaccines & immunotherapeutics, 2020-03, Vol.16 (3), p.554-561

2020

Volltextzugriff (PDF)

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

Indian journal of medical research (New Delhi, India : 1994), 2015-11, Vol.142 (5), p.525

2015

Volltextzugriff (PDF)

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Infectious agents and cancer, 2023-05, Vol.18 (1), p.29-29, Article 29

2023

Volltextzugriff (PDF)

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial

Human vaccines & immunotherapeutics, 2016-12, Vol.12 (12), p.3177-3185

2016

Volltextzugriff (PDF)

"You Don't Know If It's the Truth or a Lie": Exploring Human Papillomavirus (HPV) Vaccine Hesitancy among Communities with Low HPV Vaccine Uptake in Northern California

Vaccines (Basel), 2024-04, Vol.12 (4), p.372

2024

Volltextzugriff (PDF)

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Vaccine, 2011-06, Vol.29 (28), p.4601-4607

2011

Volltextzugriff (PDF)

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Frontiers in immunology, 2020-05, Vol.11, p.1012-1012

2020

Volltextzugriff (PDF)

Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344248-2344248

2024

Volltextzugriff (PDF)

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2313249-2313249

2024

Volltextzugriff (PDF)

Chinese mothers' intention to vaccinate daughters against human papillomavirus (HPV), and their vaccine preferences: a study in Fujian Province

Human vaccines & immunotherapeutics, 2021-01, Vol.17 (1), p.304-315

2021

Volltextzugriff (PDF)

Immunotherapy of a human papillomavirus (HPV) type 16 E7‐expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette–Guérin (BCG) hsp65 and HPV16 E7

Clinical and experimental immunology, 2000-08, Vol.121 (2), p.216-225

2000

Volltextzugriff (PDF)

Early impact of Ontario’s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment

Vaccine, 2016-09, Vol.34 (39), p.4678-4683

2016

Volltextzugriff (PDF)

School Teachers' Perceptions of Adolescent Human Papillomavirus (HPV) Vaccination: A Systematic Review

Vaccines (Basel), 2024-04, Vol.12 (4), p.361

2024

Volltextzugriff (PDF)

Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review

Vaccines (Basel), 2021-11, Vol.9 (11), p.1360

2021

Volltextzugriff (PDF)

Factors Associated with College Students' Human Papillomavirus (HPV) Vaccination and Preferred Strategies for Catch-Up Vaccine Promotion: A Mixed-Methods Study

Vaccines (Basel), 2023-06, Vol.11 (6), p.1124

2023

Volltextzugriff (PDF)

Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review

Vaccines (Basel), 2021-05, Vol.9 (5), p.496

2021

Volltextzugriff (PDF)

The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: A systematic review of observational studies in the United States

Vaccine, 2012-06, Vol.30 (31), p.4588-4595

2012

Volltextzugriff (PDF)

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma

Indian journal of medical research (New Delhi, India : 1994), 2015-11, Vol.142 (5), p.507

Sastre-Garau, Xavier

2015

Volltextzugriff (PDF)

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years

Human vaccines & immunotherapeutics, 2020-06, Vol.16 (6), p.1392-1403

2020

Volltextzugriff (PDF)

'I also want to be vaccinated!' - adolescent boys' awareness and thoughts, perceived benefits, information sources, and intention to be vaccinated against Human papillomavirus (HPV)

Human vaccines & immunotherapeutics, 2019-08, Vol.15 (7-8), p.1794-1802

2019

Volltextzugriff (PDF)

Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada's three largest cities

Human vaccines & immunotherapeutics, 2021-12, Vol.17 (12), p.5413-5425

2021

Volltextzugriff (PDF)

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial

Human vaccines & immunotherapeutics, 2015, Vol.11 (7), p.1689-1702

2015

Volltextzugriff (PDF)

Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus -based therapeutic HPV vaccine in a synergistic manner

Vaccine, 2012-08, Vol.30 (36), p.5368-5372

2012

Volltextzugriff (PDF)

1 – 25 von 3.314

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

PublikationsformReviews

ThemaMiddle Aged

KollektionIngentaConnect Journals

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.287)
Mit Volltextzugriff
(3.195)

Publikationsform

Artikel
(3.313)
Tagungsberichte
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.288)
Life Sciences & Biomedicine
(3.167)
Humans
(1.748)
Human Papillomavirus
(1.714)
Vaccines
(1.474)
Medicine, Research & Experimental
(1.449)
Research & Experimental Medicine
(1.449)
Female
(1.126)
Cervical Cancer
(935)
Vaccination
(858)
Immunization
(830)
Allergy And Immunology
(817)
Papillomavirus Infections - Prevention & Control
(655)
Infections
(611)
Cancer
(598)
Biotechnology & Applied Microbiology
(593)
Adolescent
(509)
Hpv
(499)
Review
(474)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(729)
Vaccines
(631)
Human Vaccines & Immunotherapeutics
(583)
Infectious Agents And Cancer
(329)
Plos One
(114)
Frontiers In Immunology
(93)
Frontiers In Cellular And Infection Microbiology
(65)
Indian Journal Of Medical Research
(55)
Aids
(38)
Immunology
(32)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial

"You Don't Know If It's the Truth or a Lie": Exploring Human Papillomavirus (HPV) Vaccine Hesitancy among Communities with Low HPV Vaccine Uptake in Northern California

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years

Chinese mothers' intention to vaccinate daughters against human papillomavirus (HPV), and their vaccine preferences: a study in Fujian Province

Immunotherapy of a human papillomavirus (HPV) type 16 E7‐expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette–Guérin (BCG) hsp65 and HPV16 E7

Early impact of Ontario’s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment

School Teachers' Perceptions of Adolescent Human Papillomavirus (HPV) Vaccination: A Systematic Review

Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review

Factors Associated with College Students' Human Papillomavirus (HPV) Vaccination and Preferred Strategies for Catch-Up Vaccine Promotion: A Mixed-Methods Study

Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review

The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: A systematic review of observational studies in the United States

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years

'I also want to be vaccinated!' - adolescent boys' awareness and thoughts, perceived benefits, information sources, and intention to be vaccinated against Human papillomavirus (HPV)

Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada's three largest cities

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial

Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus -based therapeutic HPV vaccine in a synergistic manner

Aktive Filter

Suchergebnisse filtern